Cargando…

Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy

Detalles Bibliográficos
Autores principales: Lanoy, E, Rosenberg, PS, Fily, F, Lascaux, AS, Martinez, V, Partisani, M, Poizot-Martin, I, Rouveix, E, Engels, EA, Costagliola, D, Goedert, JJ
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002734/
http://dx.doi.org/10.1186/1750-9378-5-S1-A71
_version_ 1782193774646001664
author Lanoy, E
Rosenberg, PS
Fily, F
Lascaux, AS
Martinez, V
Partisani, M
Poizot-Martin, I
Rouveix, E
Engels, EA
Costagliola, D
Goedert, JJ
author_facet Lanoy, E
Rosenberg, PS
Fily, F
Lascaux, AS
Martinez, V
Partisani, M
Poizot-Martin, I
Rouveix, E
Engels, EA
Costagliola, D
Goedert, JJ
author_sort Lanoy, E
collection PubMed
description
format Text
id pubmed-3002734
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30027342010-12-16 Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy Lanoy, E Rosenberg, PS Fily, F Lascaux, AS Martinez, V Partisani, M Poizot-Martin, I Rouveix, E Engels, EA Costagliola, D Goedert, JJ Infect Agent Cancer Meeting Abstracts BioMed Central 2010-10-11 /pmc/articles/PMC3002734/ http://dx.doi.org/10.1186/1750-9378-5-S1-A71 Text en Copyright ©2010 Lanoy et al; licensee BioMed Central Ltd.
spellingShingle Meeting Abstracts
Lanoy, E
Rosenberg, PS
Fily, F
Lascaux, AS
Martinez, V
Partisani, M
Poizot-Martin, I
Rouveix, E
Engels, EA
Costagliola, D
Goedert, JJ
Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
title Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
title_full Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
title_fullStr Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
title_full_unstemmed Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
title_short Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
title_sort risk of hiv-associated hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
topic Meeting Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002734/
http://dx.doi.org/10.1186/1750-9378-5-S1-A71
work_keys_str_mv AT lanoye riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT rosenbergps riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT filyf riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT lascauxas riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT martinezv riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT partisanim riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT poizotmartini riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT rouveixe riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT engelsea riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT costagliolad riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy
AT goedertjj riskofhivassociatedhodgkinlymphomaduringthefirstmonthsafterinitiationofcombinationantiretroviraltherapy